Table 2 Distributions of alleles and genotypes between T2DM patients and control subjects
Polymorphism | T2DM | Non-diabetic | Unadjusted Pa | Adjusted OR(95% CI)/Pb |
|---|---|---|---|---|
rs3806318 | n = 925 | n = 1038 |  |  |
 AA | 741(80.1%) | 827(79.7%) | 0.964 | 1 |
 AG | 173(18.7%) | 199(19.2%) |  | 1.038(0.650–1.660)/0.875 |
 GG | 11(1.2%) | 12(1.1%) |  | 0.971(0.638–1.476)/0.889 |
 A | 1655(89.5%) | 1162(89.3%) | 0.839 | 1 |
 G | 195(10.5%) | 128(10.7%) |  | 0.999(0.811–1.231)/0.995 |
rs1327118 | n = 922 | n = 1031 |  |  |
 CC | 726(79.7%) | 798(77.4%) | 0.721 | 1 |
 CG | 178(19.2%) | 214(20.8%) |  | 1.063(0.712–1.588)/0.764 |
 GG | 18(1.1%) | 19(1.8%) |  | 1.011(0.716–1.427)/0.952 |
 C | 1630(88.4%) | 1810(87.8%) | 0.562 | 1 |
 G | 214(11.6%) | 252(12.2%) |  | 1.055(0.866–1.286)/0.593 |